Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |